ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix
|
|
whytee
|
47 |
14K |
1 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
47
|
14K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
422K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.3K
|
422K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
6
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.7K |
9 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.7K
|
9
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.7K |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.7K
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.7K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.7K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.8K |
2.9M |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
5.8K
|
2.9M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.8K |
2.9M |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
5.8K
|
2.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
9.8K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
42K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
42K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
9.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
422K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.3K
|
422K
|
1
|
|
ASX - By Stock
|
OIL |
Re:
Ann: OIL June 2024 Quarterly Report and Appendix 4C
|
|
whytee
|
6 |
2.1K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
6
|
2.1K
|
4
|
|
ASX - By Stock
|
OIL |
Re:
Ann: OIL June 2024 Quarterly Report and Appendix 4C
|
|
whytee
|
6 |
2.1K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
6
|
2.1K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
42K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
42K
|
0
|
|
ASX - By Stock
|
OIL |
Re:
Ann: OIL June 2024 Quarterly Report and Appendix 4C
|
|
whytee
|
6 |
2.1K |
6 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
6
|
2.1K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
42K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
42K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
42K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
42K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
42K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
42K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
6 |
2.3K |
3 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
6
|
2.3K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
42K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
42K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.3M |
7 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
12K
|
6.3M
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.3M |
11 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
12K
|
6.3M
|
11
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix
|
|
whytee
|
47 |
14K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
47
|
14K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix
|
|
whytee
|
47 |
14K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
47
|
14K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.3M |
9 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
12K
|
6.3M
|
9
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
16 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
189
|
63K
|
16
|
|
ASX - By Stock
|
PNV |
Re:
We`re having a good time
|
|
whytee
|
2 |
1.5K |
13 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
2
|
1.5K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
42K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
42K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.8K |
2.9M |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
5.8K
|
2.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.8K |
2.9M |
9 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
5.8K
|
2.9M
|
9
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
7 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
189
|
63K
|
7
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
whytee
|
720 |
251K |
5 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
720
|
251K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
6 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
189
|
63K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
whytee
|
18K |
7.0M |
0 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
18K
|
7.0M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
13 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
189
|
63K
|
13
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
63K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
63K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
63K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
63K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
whytee
|
943 |
411K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
943
|
411K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
1 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
63K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
63K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
63K
|
2
|
|